American Health Officials Block Release of Key Study on COVID-19 Vaccine Effectiveness – What’s Behind the Controversy?
- Health officials have stopped the publication of a study examining the effectiveness of COVID-19 vaccines in preventing hospitalizations and emergency room visits among adults, according to multiple news...
- The research paper, which had cleared the agency's scientific-review process, was scheduled to appear in the Morbidity and Mortality Weekly Report (MMWR), the Centers for Disease Control and...
- Following the same approach used in previously published studies in journals such as Pediatrics and the New England Journal of Medicine, the researchers focused on sick people who...
U.S. Health officials have stopped the publication of a study examining the effectiveness of COVID-19 vaccines in preventing hospitalizations and emergency room visits among adults, according to multiple news reports.
The research paper, which had cleared the agency’s scientific-review process, was scheduled to appear in the Morbidity and Mortality Weekly Report (MMWR), the Centers for Disease Control and Prevention’s flagship publication. A U.S. Department of Health and Human Services spokesman confirmed the decision to halt publication, citing a dispute about the study’s methodology.
Following the same approach used in previously published studies in journals such as Pediatrics and the New England Journal of Medicine, the researchers focused on sick people who were admitted to hospitals or visited emergency rooms. They checked whether patients were vaccinated and then calculated the odds of a positive COVID-19 test among vaccinated patients compared to those who were unvaccinated.
According to The Washington Post, which first reported the cancellation, the study concluded that the vaccine cut emergency room visits and hospitalizations among otherwise healthy adults by about half during the past winter. HHS officials did not specify exactly why the methodology was problematic in this instance but noted that prior infection, behavior, and differences in who seeks care can affect results.
The wider scientific community does not share these concerns, and many researchers have continued to use this approach. Dr. Fiona Havers, an Atlanta-based doctor who previously worked at the CDC, stated that the methodology is widely accepted in the field.
This development comes amid ongoing discussions about vaccine effectiveness monitoring and public health communication strategies. The MMWR has served as a key vehicle for disseminating timely public health information and scientific findings throughout the pandemic.
As of April 24, 2026, the study remains unpublished, and officials have not indicated whether it will be revised for future submission or released through alternative channels.
